The information in this website is intended only for healthcare professionals. By entering this site, you are confirming that you are a healthcare professional.
The information in this website is intended only for laboratory professionals. By entering this site, you are confirming that you are a laboratory professional.
For the past 50 years, our commitment to science has led the way to our introduction of unique pioneering assays and technologies to aid in the accurate diagnosis of disease.
From the global leader of in vitro assays for determination of allergen specific and autoimmune disease antibodies, PhadiaTM Laboratory Systems provide efficient and robust solutions to help provide results that may optimize the diagnosis of allergic and autoimmune diseases.
Our science is our focus. Advanced technology is at the heart of everything we do, and Phadia Laboratory Systems are built on that commitment.
With the prevalence of allergic diseases steadily increasing, the importance of high-quality reagents has never been greater. Based in Sweden, our facilities produce an extensive range of raw materials for ImmunoCAPTM assays including pollen, mold, mite, epithelia and food source material. For our autoimmunity assays, manufacturing of materials based largely on recombinant proteins allows greater reliability of results across the EliATM test menu.
More than 1,000 quality-control procedures ensure the purity of our products—so your laboratory can rely on the integrity of the results.
EliA immunoassays combine high sensitivity with exceptional specificity to consistently deliver reliable results that can be applied clinically, with confidence.
Studies show that anti-CCP2 assays, such as the EliA CCP test demonstrate fewer false positive results as compared to non-CCP2 methods.1
Phadia Laboratory Systems offer your laboratory the capacity to run both ImmunoCAP and EliA assays on a single instrument.*
*With the exception of PhadiaTM 1000